|
Volumn 95, Issue 8, 2005, Pages 568-574
|
Valvular heart disease in South Africa in 2005
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
ARTICLE;
BACTERIAL ENDOCARDITIS;
COMPETENCE;
CONTINUING EDUCATION;
FINANCIAL MANAGEMENT;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH CARE DELIVERY;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH CARE SYSTEM;
HEALTH PERSONNEL ATTITUDE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDICAL EDUCATION;
MEDICAL RESEARCH;
MEDICAL SPECIALIST;
MITRAL VALVE COMMISSUROTOMY;
MITRAL VALVE PROLAPSE;
MITRAL VALVE REPLACEMENT;
MITRAL VALVE STENOSIS;
PATIENT CARE;
POSTGRADUATE EDUCATION;
RESOURCE ALLOCATION;
RESPONSIBILITY;
RHEUMATIC HEART DISEASE;
SAFETY;
SOUTH AFRICA;
TRANSLUMINAL VALVULOPLASTY;
TREATMENT OUTCOME;
VALVULAR HEART DISEASE;
DELIVERY OF HEALTH CARE;
DEVELOPING COUNTRIES;
FEMALE;
HEALTH CARE COSTS;
HEALTH RESOURCES;
HEALTH SERVICES NEEDS AND DEMAND;
HEART VALVE DISEASES;
HUMANS;
INCIDENCE;
MALE;
ORGANIZATIONAL POLICY;
PRIVATIZATION;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SOCIOECONOMIC FACTORS;
SOUTH AFRICA;
TOTAL QUALITY MANAGEMENT;
|
EID: 23844507987
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (4)
|